NCT06435429 · Interventional trial
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
Overall registry status Recruiting
Phase 3
Conditions Metastatic HER2-positive Breast Cancer
Delaware Valley sites
- Abramson Cancer Center of The University of Pennsylvania · Philadelphia, PA · Philadelphia County · Recruiting
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory